BiotechTube
Home/NeuroKappa Therapeutics/John Grothusen, PhD
JG

John Grothusen, PhD

CSO (Chief Scientific Officer)

NeuroKappa Therapeutics

Therapeutic Areas

StrokePain ManagementAddiction TherapyDepression

NeuroKappa Therapeutics Pipeline

DrugIndicationPhase
Salvinorin A Novel AnalogStroke (Neuroprotection)Pre-clinical
Dezocine & Associated ProductsOpioid Addiction Management / PainPre-clinical

Leadership Team at NeuroKappa Therapeutics

PF
Peter Fang, MD, MS
CEO
RL
Renyu Liu, MD, PhD
Founder
GB
Gordon Barr, PhD
DMD (likely Director of Medicinal Chemistry)
LF
Lei Fang, Esq, MD, PhD
Legal Counsel
YC
Yi-yen Chen, PhD
Business Development
View full NeuroKappa Therapeutics profile